CanSense

Swansea, United Kingdom

CanSense is an accurate, rapid, non-invasive, blood diagnostic for the early detection of cancer.

$1.8M raised

Mar 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CanSense raised?

CanSense has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in March 2023.

Who are CanSense's investors?

CanSense's investors include Development Bank of Wales, Mercia Fund Managers, National Institute for Health and Care Research, Nonacus.

Where is CanSense headquartered?

CanSense is headquartered in Swansea, United Kingdom.

What does CanSense do?

CanSense is an accurate, rapid, non-invasive, blood diagnostic for the early detection of cancer.

What stage is CanSense at?

CanSense is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 8, 2023.

MLA

"CanSense — Funding & Investors." VCBacked, March 8, 2023, https://www.vcbacked.co/company/cansense. Accessed July 2, 2026.

APA

VCBacked. (2023). CanSense — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cansense

Wikipedia (cite web)

{{cite web |title=CanSense — Funding & Investors |url=https://www.vcbacked.co/company/cansense |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 8, 2023.